The impact of transanal local excision of early rectal cancer on completion rectal resection without neoadjuvant chemoradiotherapy: a systematic review.

Completion proctectomy Completion rectal resection Early anterior resection Early rectal cancer Early salvage proctectomy Surgical transanal excision Transanal endoscopic microsurgery

Journal

Techniques in coloproctology
ISSN: 1128-045X
Titre abrégé: Tech Coloproctol
Pays: Italy
ID NLM: 9613614

Informations de publication

Date de publication:
09 2021
Historique:
received: 17 04 2020
accepted: 28 12 2020
pubmed: 27 6 2021
medline: 24 8 2021
entrez: 26 6 2021
Statut: ppublish

Résumé

The impact of transanal local excision (TAE) of early rectal cancer (ERC) on subsequent completion rectal resection (CRR) for unfavorable histology or margin involvement is unclear. The aim of this study was to provide a comprehensive review of the literature on the impact of TAE on CRR in patients without neoadjuvant chemoradiotherapy (CRT). We performed a systematic review of the literature up to March 2020. Medline and Cochrane libraries were searched for studies reporting outcomes of CRR after TAE for ERC. We excluded patients who had neoadjuvant CRT and endoscopic local excision. Surgical, functional, pathological and oncological outcomes were assessed. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were followed. Sixteen studies involving 353 patients were included. Pathology following TAE was as follows T0 = 2 (0.5%); T1 = 154 (44.7%); T2 = 142 (41.2%); T3 = 43 (12.5%); Tx = 3 (0.8%); T not reported = 9. Fifty-three percent were > T1. Abdominoperineal resection (APR) was performed in 80 (23.2%) patients. Postoperative major morbidity and mortality occurred in 22 (11.4%) and 3 (1.1%), patients, respectively. An incomplete mesorectal fascia resulting in defects of the mesorectum was reported in 30 (24.6%) cases. Thirteen (12%) patients developed recurrence: 8 (3.1%) local, 19 (7.3%) distant, 4 (1.5%) local and distant. The 5-year cancer-specific survival was 92%. Only 1 study assessed anal function reporting no continence disorders in 11 patients. In the meta-analysis, CRR after TAE showed an increased APR rate (OR 5.25; 95% CI 1.27-21.8; p 0.020) and incomplete mesorectum rate (OR 3.48; 95% CI 1.32-9.19; p 0.010) compared to primary total mesorectal excision (TME). Two case matched studies reported no difference in recurrence rate and disease free survival respectively. The data are incomplete and of low quality. There was a tendency towards an increased risk of APR and poor specimen quality. It is necessary to improve the accuracy of preoperative staging of malignant rectal tumors in patients scheduled for TAE.

Sections du résumé

BACKGROUND
The impact of transanal local excision (TAE) of early rectal cancer (ERC) on subsequent completion rectal resection (CRR) for unfavorable histology or margin involvement is unclear. The aim of this study was to provide a comprehensive review of the literature on the impact of TAE on CRR in patients without neoadjuvant chemoradiotherapy (CRT).
METHODS
We performed a systematic review of the literature up to March 2020. Medline and Cochrane libraries were searched for studies reporting outcomes of CRR after TAE for ERC. We excluded patients who had neoadjuvant CRT and endoscopic local excision. Surgical, functional, pathological and oncological outcomes were assessed. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were followed.
RESULTS
Sixteen studies involving 353 patients were included. Pathology following TAE was as follows T0 = 2 (0.5%); T1 = 154 (44.7%); T2 = 142 (41.2%); T3 = 43 (12.5%); Tx = 3 (0.8%); T not reported = 9. Fifty-three percent were > T1. Abdominoperineal resection (APR) was performed in 80 (23.2%) patients. Postoperative major morbidity and mortality occurred in 22 (11.4%) and 3 (1.1%), patients, respectively. An incomplete mesorectal fascia resulting in defects of the mesorectum was reported in 30 (24.6%) cases. Thirteen (12%) patients developed recurrence: 8 (3.1%) local, 19 (7.3%) distant, 4 (1.5%) local and distant. The 5-year cancer-specific survival was 92%. Only 1 study assessed anal function reporting no continence disorders in 11 patients. In the meta-analysis, CRR after TAE showed an increased APR rate (OR 5.25; 95% CI 1.27-21.8; p 0.020) and incomplete mesorectum rate (OR 3.48; 95% CI 1.32-9.19; p 0.010) compared to primary total mesorectal excision (TME). Two case matched studies reported no difference in recurrence rate and disease free survival respectively.
CONCLUSIONS
The data are incomplete and of low quality. There was a tendency towards an increased risk of APR and poor specimen quality. It is necessary to improve the accuracy of preoperative staging of malignant rectal tumors in patients scheduled for TAE.

Identifiants

pubmed: 34173121
doi: 10.1007/s10151-020-02401-8
pii: 10.1007/s10151-020-02401-8
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

997-1010

Informations de copyright

© 2021. Springer Nature Switzerland AG.

Références

Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cer-vantes A, Arnold D (2017) Rectal cancer ESMO clinical practice guidelines. Ann Oncol 28(suppl 4):iv22–iv40
pubmed: 28881920 doi: 10.1093/annonc/mdx224 pmcid: 28881920
Eid Y, Alves A, Lubrano J, Menahem B (2018) Does previous transanal excision for early rectal cancer impair surgical outcomes and pathologic findings of completion total mesorectal excision? Results of a systematic review of the literature. J Visc Surg 155(6):445–452
pubmed: 29657063 doi: 10.1016/j.jviscsurg.2018.03.008 pmcid: 29657063
Jones HJS, Cunnningham C, Nicholson GA, Hompes R (2018) Outcomes following completion and salvage surgery for early rectal cancer: a systematic review. Eur J Surg Oncol 44:15–23
pubmed: 29174708 doi: 10.1016/j.ejso.2017.10.212 pmcid: 29174708
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Pre- ferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. 6(7)
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chip-poni J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73(9):712–716
pubmed: 12956787 doi: 10.1046/j.1445-2197.2003.02748.x pmcid: 12956787
AsayamaN SO, Shinji T, Yuki N, Yuzuru T, Kenjiro S, Nana H, Hiroyouki E, Takao H, Hideki O, Koji AK, Chayama K (2016) Long term outcomes after treatment for T1 colorectal carcinoma. Int J Colorctal Dis 31:571–578
doi: 10.1007/s00384-015-2473-6
Gagliardi G, Newton TR, Balley HR (2013) Local excision of rectal cancer followed by radical surgery because of poor prognostic features does not compromise the long term oncologic outcome. Colorectal Dis 15:e659-664
pubmed: 24033889 doi: 10.1111/codi.12387 pmcid: 24033889
Hahnloser D, Wolff BG, Larson DW, Ping J, Nivatvongs S (2005) Immediate radical resection after local excision of rectal cancer: an oncologic compromise. Dis Colon Rectum 48(3):429–437
pubmed: 15747069 doi: 10.1007/s10350-004-0900-9 pmcid: 15747069
Baron PL, Enker WE, Zakowski MF, Urmacher C (1995) Immediate vs salvage resection after local treatment for early rectal cancer. Dis Colon Rectum 5(38):177–181
doi: 10.1007/BF02052447
Piessen G, Cabral C, Benoist S, Penna C, Nordlinger B (2012) Previous transanal full-thickness excision increases the morbidity of radical resection for rectal cancer. Colorectal Dis 14(4):445–452
pubmed: 21689342 doi: 10.1111/j.1463-1318.2011.02671.x
Baatrup G, Breum B, Qvist N, Wille Jorgensen P, Elbrond H, Moller P, Hesselfeldt P (2009) Transanal endoscopic microsurgery in 143 patients with rectal adenocarcinoma: results from a Danish multicenter study. Colorctal Dis 11:270–275
doi: 10.1111/j.1463-1318.2008.01600.x
Junginger T, Goenner U, Hitzler M, Trinh TT, Heintz A, Wol- lschläger D (2019) Local excision followed by early radical surgery in rectal cancer: long-term outcome. World J Surg Oncol 17(1):168
pubmed: 31594546 pmcid: 6784329 doi: 10.1186/s12957-019-1705-6
Dulsksas A, Atkociunas A, Kilius A, Petrulis K, Samalavicius NE (2019) Is previous transanal endoscopic microsurgery for early rectal cancer a risk factor for worse outcome following salvage surgery? A case-matched analysis. Visc Med 35:151–155
doi: 10.1159/000493281
Issa N, Fenig Y, Gingold-Belfer R, Khatib M, Wisam K, Wolf-sonSchmilotz-Weiss LH (2018) Laparoscopic total mesorectal excision following transanal endoscopic microsurgery for rectal cancer. J Laparoendosc Adv Surg Tech 8:977–982
doi: 10.1089/lap.2017.0399
Coton C, Lefevre JH, Debove C, Cravin B, Chafai N, Tiret E, Parc Y (2018) Does transanal local resection increase morbidity for subsequent total mesorectal excision for early rectal cancer? Colorectal Dis 21(1):15–22
pubmed: 30300969 doi: 10.1111/codi.14445
Gudbrand C, Pachler JH, Bulut O (2018) Transanal completion TME as early salvage after TEM in rectal cancer—a short report. Clin Surg 3:2259
Osman KA, Ryan D, Afshar S, Mohamed ZK, Garg D, Gill T (2015) Transanal endoscopic microsurgery for rectal cancer: University Hospital of North Teets experience. Indian J Surg 77:930–935
pubmed: 27011485 doi: 10.1007/s12262-014-1067-9
Hompes R, Mc Donald R, Buskens C, Lindsey I, Armitage N, Hill J, Scott A, Mortensen NJ and Cunningham C on behalf of the Association of Coloproctology of Great Britain and Ireland Transanal Endoscopic Microsurgery Collaboration (2013) Completion surgery following transanal endoscopic microsurgery: assessment of quality and short-and long-term outcome. Colo- rectal Dis 15(10):e576–e581
doi: 10.1111/codi.12381
Morino M, Allaix ME, Arolfo S, Arezzo A (2013) Previous transanal endoscopic microsurgery for rectal cancer represents a risk factor for an increased abdominoperineal resection rate. Surg Endosc 27(9):3315–3321
pubmed: 23479257 doi: 10.1007/s00464-013-2911-x
Levic K, Bulut O, Hesselfeldt P, Bulow S (2013) The outcome of rectal cancer after early salvage TME following TEM com- pared with primary TME: a case-matched study. Tech Coloproct 17(4):397–403
doi: 10.1007/s10151-012-0950-2
Bach SP, Hill J, Monson JRT, Simson JNL, Lane L, Merrie A, Warren B, Mortensen NJ, on behalf of the Association of Colo- proctology of Great Britain and Ireland Transanal Endoscopic Microsurgery (TEM) Collaboration (2009) A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg 96(3):280–290
doi: 10.1002/bjs.6456
Nash GM, Weiser MR, Guillem JG, Temple LK, Shia J, Gonen M, Wong WD, Paty PB (2009) Long-term survival after transanal excision of T1 rectal cancer. Dis Colon Rectum 52(4):577–582
pubmed: 19404055 doi: 10.1007/DCR.0b013e3181a0adbd
Borschitz T, Gockel I, Kiesslich R, Junginger T (2008) Oncological outcome after local excision of rectal carcinomas. Ann Surg Oncol 15(11):3101–3108
pubmed: 18719965 doi: 10.1245/s10434-008-0113-x
Bretagnol F, Merrie A, George B, Warren BF, Mortense NJ (2007) Local excision of rectal tumours by transanal endoscopic microsurgery. Br J Surg 94:627–633
pubmed: 17335125 doi: 10.1002/bjs.5678
Lee YW, Lee WS, Yun SH, Shin SH, Chua HK (2007) Decision for salvage treatment after transanal endoscopic microsurgery. Surg Endosc 21:975–979
pubmed: 17623251 doi: 10.1007/s00464-006-9170-z
Min BS, Kim NK, Ko YT, Lee KY, Baek SH, Cho CH, Sohn SK (2007) Long-term oncologic results of patients with distal rectal cancer treated by local excision with or without adjuvant treatment. Int J Colorectal Dis 22(11):1325–1330
pubmed: 17571241 doi: 10.1007/s00384-007-0339-2
Nakagoe T, Ishikawa H, Sawai T, Tsuji T (2004) Long-term out- comes of radical surgery after gasless video endoscopic transanal excision of T1/T2 rectal cancers. EJSO 30:638–642
pubmed: 15256238 doi: 10.1016/j.ejso.2004.04.010
Nicholls RJ, Zinicola R, Binda GA (2004) Indications for colorectal resection for adenoma before and after polypectomy. Techn Coloproctol 8:291–294
doi: 10.1007/s10151-004-0179-9
Morino M, Risio M, Bach S, Beets-Tan R, Krzystzof B, Panis Y, Quirke P, Rembacken B, Rullier E, Saito Y, Young-Fadok T, Alliax ME (2015) Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference. Surg Endosc 29(4):755–773
pubmed: 25609317 doi: 10.1007/s00464-015-4067-3
Chambers WM, Khan U, Gagliano A, Smith RD, Sheffeld J, Nicholls RJ (2004) Tumour morphology as a predictor of outcome after local excision of rectal cancer. Br J Surg 91(4):457–459
pubmed: 15048747 doi: 10.1002/bjs.4504 pmcid: 15048747
Maeda K, Koide Y, Katsuno H (2014) When is local excision appropriate for “early” rectal cancer? Surg Today 44(11):2000–2014
pubmed: 24254058 doi: 10.1007/s00595-013-0766-3 pmcid: 24254058
York Mason A (1976) Rectal cancer: the spectrum of selective surgery. Proc Roy Soc Med 69:237–244
doi: 10.1177/003591577606900401
Kneist W, Terzic A, Burghardt J, Heintz A, Junginger T (2004) Selection of patients with rectal tumors for local excision based on preoperative diagnosis. Results of a consecutive evaluation study of 552 patients. Chirurg 75(2):168–175
pubmed: 14991179 doi: 10.1007/s00104-003-0746-z pmcid: 14991179
Ishiguro A, Uno Y, Ishiguro Y, Munakata A, Morita T (1999) Correlation of lifting versus non lifting and microscopic depth of invasion in early colorectal cancer. Gastrointest Endosc 50(3):329–333
pubmed: 10462651 doi: 10.1053/ge.1999.v50.98591 pmcid: 10462651
Kobayashi N, Saito Y, Sano Y et al (2007) Determining the treatment strategy for colorectal neoplastic lesions: endoscopic assessment or the non-lifting sign for diagnosing invasion depth? Endoscopy 39(8):701–705
pubmed: 17661244 doi: 10.1055/s-2007-966587 pmcid: 17661244
Ikehara H, Saito Y, Matsuda T, Iraoka T, Murakami Y (2010) Diagnosis of depth invasion for early colorectal cancer using magnifying colonoscopy. J Gastroenterol Hepatol 25(5):905–912
pubmed: 20546444 doi: 10.1111/j.1440-1746.2010.06275.x pmcid: 20546444
Puli SR, Bechtold ML, Reddy JB, Choudhary A, Antillon MR, Brugge WR (2009) How good is endoscopic ultrasound in differentiating various T stages of rectal cancer? Meta-analysis and systematic review. Ann Surg Oncol 16(2):254–265
pubmed: 19018597 doi: 10.1245/s10434-008-0231-5 pmcid: 19018597
Ashraf S, Hompes R, Slater A, Lindsey I, Bachj S, Mortensen NJ, Cunningham C, Association of Coloproctology of Great Britain and Ireland Transanal Endoscopic Microsurgery (TEM) Collaboration (2012) A critical appraisal of endorectal ultrasound and transanal endoscopic microsurgery and decision-making in early rectal cancer. Colorectal Dis 14(7):821–826
pubmed: 21920011 doi: 10.1111/j.1463-1318.2011.02830.x pmcid: 21920011
Marusch F, Koch A, Schmidt U, Zippel R, Kuhn R, Wolff S, Pross A, Wierth A, Gastinger I, Lippert H (2002) Routine use of transrectal ultrasound in rectal carcinoma: results of a prospective multicenter study. Endoscopy 34(5):385–390
pubmed: 11972270 doi: 10.1055/s-2002-25292 pmcid: 11972270
Mor I, Hull T, Hammel J, Zutshi M (2010) Rectal endosonography: just how good are we at its interpretation? Int J Colorectal Dis 25(1):87–90
pubmed: 19844728 doi: 10.1007/s00384-009-0816-x
Williams JG, Pullan RD, Hill J, Horgan PG, Salmo E, Buchanan GN, Rasheed S, McGee SG, Haboubi N, Association of Coloproctology of Great Britain and Ireland (2013) Management of the malignant colorectal polyp: ACPGBI position statement. Colorectal Dis 2:1–38
doi: 10.1111/codi.12262
Lee BI, Matsuda T (2019) Estimation of invasion depth: the first key to successful colorectal ESD. Clinical Endoscopy 52(2):100–106
pubmed: 30914629 pmcid: 6453840 doi: 10.5946/ce.2019.012
Haji A, Adams K, Bjarnason I, Papagrigoriadis S (2014) High-frequency mini probe ultrasound before endoscopic resection of colorectal polyps—is it useful? Dis Colon Rectum 57(3):378–382
pubmed: 24509463 doi: 10.1097/DCR.0b013e3182a0e39c
Matsuda T, Fujii T, Saito Y, Nakajima T, Uraoka T, Kobayashi N, Ikehara H, Ikematsu H, Fu KI, Emura F, Ono A, Sano Y, Shi-moda T, Fujimori T (2008) Efficacy of the invasive/non-invasive pattern by magnifying chromoendoscopy to estimate the depth of invasion of early colorectal neoplasms. Am J Gastroenterol 103(11):2700–2706
pubmed: 18853968 doi: 10.1111/j.1572-0241.2008.02190.x pmcid: 18853968
Zhang JJ, Gu LY, Chen XY, Gao YJ, Ge ZZ, Li XB (2015) Endoscopic diagnosis of invasion depth for early colorectal carcinomas. A prospective comparative study of narrow-band imaging, acetic acid, and crystal violet. Medicine 94(7):e528
pubmed: 25700314 pmcid: 4554180 doi: 10.1097/MD.0000000000000528
Takeda K, Kudo SE, Mori Y, Misawa M, Kudo T, Wakamura K, Katagiri A, Baba T, Hidaka E, Ishida F, Inoue H, Oda M, Mori K (2017) Accuracy of diagnosing invasive colorectal cancer using computer-aided endocytoscopy. Endoscopy 49(8):798–802
pubmed: 28472832 doi: 10.1055/s-0043-105486 pmcid: 28472832
Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2(8514):996–999
pubmed: 2430152 doi: 10.1016/S0140-6736(86)92612-7 pmcid: 2430152
Van Gijn W, Brehm V, De Graaf E, Neijenhuis PA, Stassen LP, Leijtens JW, Van De Velde CJ, Doornebosch PG (2013) Unexpected rectal cancer after TEM: outcome of completion surgery compared with primary TME. Eur J Surg Oncol 39(11):1225–1229
pubmed: 23972571 doi: 10.1016/j.ejso.2013.08.003 pmcid: 23972571
Marks JH, Frenkel JL, D’Andrea AP, Greenleaf CE (2011) Maxi- mizing rectal cancer results: TEM and TATA techniques to expand sphincter preservation. Surg Oncol Clin N Am 20(3):501–520
pubmed: 21640918 doi: 10.1016/j.soc.2011.01.008 pmcid: 21640918
Tuech JJ, Karoui M, Lelong B, De Chaisemartin C, Bridoux V, Manceau G, Delpero JR, Hanoun L, Michot F (2015) A step toward NOTES total mesorectal excision for rectal cancer: endoscopic transanal proctectomy. Ann Surg 261(2):228–233
pubmed: 25361216 doi: 10.1097/SLA.0000000000000994
Zinicola R, Hill J, Fiocca R (2015) Surgery for colorectal polyps: histological features, current indications, critical points, future perspective and ongoing studies. Colorectal Dis 17(1):52–60
pubmed: 25511862 doi: 10.1111/codi.12822
Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, O’Callaghan C, Myint AS, Bessell E, Thompson LC, Parmar M, Stephens RJ, Sebag-Montefiore D; MRC CR07/NCIC-CTG CO16 Trial Investigators; NCRI Colorectal Cancer Study Group (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373(9666):821–828
doi: 10.1016/S0140-6736(09)60485-2
Leonard D, Penninckx F, Laenen A, Kartheuser A (2015) Scor- ing the quality of total mesorectal excision for the prediction of cancer-specific outcome. Colorectal Dis 17(5):O115–O122
pubmed: 25714054 doi: 10.1111/codi.12931
van Oostendorp SE, Smits LJH, Vroom Y, Detering R, Heymans MW, Moons LMG, Tanis PJ, de Graaf EJR, Cunnningham C, Denost Q, Kusters M, Tunyman JB (2020) Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment. Br J Surg 107:1710–1730
doi: 10.1002/bjs.11525
Verseveld M, de Wilt JHW, Elferink MAG, de Graaf EJR, Verhoef C, Powels S, Doornebosch PG (2019) Survival after local excision for rectal cancer: a population-based overview of clinical practice and outcome. Acta Oncol 58(8):1163–1166
pubmed: 31106636 doi: 10.1080/0284186X.2019.1616816
Clermonts SHEM, Koeter T, Pottel H, Stassen LPS, Wasowicz DK, and Zimmerman DDE (2020) Outcome of completion total mesorectal excision are not compromised by prior transanal minimally invasive surgery. Colorectal Dis 22:790–798
Jakubauskas M, Jotautas V, Poskus E, Mikalauskas S, Valeikate- Tauginiene G, Strupas K, Poskus T (2018) Fecal incontinence after transanal endoscopic microsurgery. Int J Colorectal Dis 33(4):467–472
pubmed: 29470728 doi: 10.1007/s00384-018-2983-0
Marinello FG, Curell A, Tapiolas I, Pellino G, Vallribera F, Espin E (2020) Systematic review of functional outcomes and quality of life after transanal endoscopic microsurgery and transanal minimally invasive surgery: a word of caution. Int J Colorectal Dis 35(1):51–67
pubmed: 31761962 doi: 10.1007/s00384-019-03439-3
Heisenberg V, Leijtens J, Slooter GD, Jansssen-Heijnen ML, Konsten JL (2020) Quality of life and bowel dysfunction after transanal endoscopic microsurgery for rectal cancer: one third of patients experience major low anterior rectal syndrome. Dig Surg 37:34–46
Hajjar A-E, Rey J-F (2020) Artificial intelligence in gastrointestinal endoscopy: general overview. Chin Med J 133(3):25
doi: 10.1097/CM9.0000000000000623
Zerz A, Muller-Stich BP, Beck J et al (2006) Endoscopic pos- terior mesorectal resection after transanal local excision of T1 carcinomas of the lower third of the rectum. Dis Colon Rectum 49:919–924
pubmed: 16612534 doi: 10.1007/s10350-005-0305-4
Sahakian AB, Aslanian HR (2018) Endoscopic submucosal dis- section for resection of submucosal tumors of the colon and rectum: within reach, or the edge of tomorrow? Gastrointest Endosc 87(2):549–551
pubmed: 29406933 doi: 10.1016/j.gie.2017.11.008
Borstlap WA, Tanis PJ, Koedam TW et al (2016) A multi-centred randomised trial of radical surgery versus adjuvant chemoradio- therapy after local excision for early rectal cancer. BMC Cancer 16:513
pubmed: 27439975 pmcid: 4955121 doi: 10.1186/s12885-016-2557-x
Rombouts AJM, Al-Najami I, Abbott NL, for STAR-TREC Collaborative Group et al (2017) Can we save the rectum by watchful waiting or transanal microsurgery following (chemo) radiotherapy versus total mesorectal excision for early rectal cancer (STAR-TREC study): protocol for a multicentre, randomised feasibility study. BMJ Open 7(12):474
doi: 10.1136/bmjopen-2017-019474

Auteurs

R Zinicola (R)

General Surgery Unit, University Hospital, Parma, Italy. rzmediterraneo@gmail.com.

R Nascimbeni (R)

Department Molecular & Translational Medicine, University of Brescia, Brescia, Italy.

R Cirocchi (R)

General Surgery Unit, University Hospital, Perugia, Italy.

G Gagliardi (G)

Department of Surgery, University of Illinois College of Medicine at Chicago, Chicago, IL, USA.

N Cracco (N)

General Surgery Unit, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.

M Giuffrida (M)

General Surgery Unit, University Hospital, Parma, Italy.

G Pedrazzi (G)

Unit Neuroscience, Department of Medicine and Surgery, Centre of Robust Statistic, University of Parma, Parma, Italy.

G A Binda (GA)

Colorectal Surgery, Biomedical Institute, Genoa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH